Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of EPIGENOMICS AG
No Price
Closing Price XETR 20.04.2026:
0,92 EUR
28.04.2026 07:29
Current Prices from EPIGENOMICS AG
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
Hamburg
EAGNAN41.HAMB
EUR
28.04.2026 07:29
0,93 EUR
-
UTC
EPGNF
USD
23.04.2026 13:30
1,12 USD
-
XETRA
ECX.F
EUR
20.04.2026 09:04
0,92 EUR
-
Share Float & Liquidity
Free Float70,94 %
Shares Float622.109,00
Shares Outstanding876.949,00
Company Profile for EPIGENOMICS AG Share
Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include hepatocellular carcinoma blood test; Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany.
